{
    "organizations": [],
    "uuid": "49db2ba93273f893d2a03c6c3c358d6709a18e1d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-kite-announces-clinical-collaborat/brief-kite-announces-clinical-collaboration-with-pfizer-idUSFWN1PD133",
    "ord_in_thread": 0,
    "title": "BRIEF-Kite Announces Clinical Collaboration With Pfizer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 36 PM / Updated 20 minutes ago BRIEF-Kite Announces Clinical Collaboration With Pfizer Reuters Staff 1 Min Read \nJan 18 (Reuters) - Gilead Sciences Inc: \n* KITE ANNOUNCES CLINICAL COLLABORATION TO EVALUATE INVESTIGATIONAL COMBINATION OF YESCARTA™ (AXICABTAGENE CILOLEUCEL) AND PFIZER’S UTOMILUMAB IN LARGE B-CELL LYMPHOMA \n* GILEAD SCIENCES INC - KITE ENTERED INTO A CLINICAL TRIAL COLLABORATION WITH PFIZER, INC \n* GILEAD SCIENCES INC - MULTI-CENTER PHASE 1/2 STUDY SPONSORED BY KITE IS EXPECTED TO BEGIN IN 2018 \n* GILEAD SCIENCES INC - RESULTS OF STUDY WILL BE USED TO EVALUATE OPTIONS FOR FURTHER DEVELOPMENT OF THE COMBINATION, OR SIMILAR COMBINATIONS Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T17:36:00.000+02:00",
    "crawled": "2018-01-18T18:06:54.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "clinical",
        "collaboration",
        "pfizer",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "gilead",
        "science",
        "inc",
        "kite",
        "announces",
        "clinical",
        "collaboration",
        "evaluate",
        "investigational",
        "combination",
        "axicabtagene",
        "ciloleucel",
        "pfizer",
        "utomilumab",
        "large",
        "lymphoma",
        "gilead",
        "science",
        "inc",
        "kite",
        "entered",
        "clinical",
        "trial",
        "collaboration",
        "pfizer",
        "inc",
        "gilead",
        "science",
        "inc",
        "phase",
        "study",
        "sponsored",
        "kite",
        "expected",
        "begin",
        "gilead",
        "science",
        "inc",
        "result",
        "study",
        "used",
        "evaluate",
        "option",
        "development",
        "combination",
        "similar",
        "combination",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}